142 related articles for article (PubMed ID: 11586209)
1. Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate.
Spetz AC; Pettersson B; Varenhorst E; Theodorsson E; Thorell LH; Hammar M
J Urol; 2001 Nov; 166(5):1720-3. PubMed ID: 11586209
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of calcitonin gene-related peptide in males with hot flushes after castration for carcinoma of the prostate.
Wyon Y; Spetz AC; Hammar M; Theodorsson E; Varenhorst E
Scand J Urol Nephrol; 2001 Apr; 35(2):92-6. PubMed ID: 11411665
[TBL] [Abstract][Full Text] [Related]
3. Prevention by 17beta-estradiol and progesterone of calcitonin gene-related peptide-induced elevation of skin temperature in castrated male rats.
Yuzurihara M; Ikarashi Y; Noguchi M; Kase Y; Takeda S; Aburada M
Urology; 2004 Nov; 64(5):1042-7. PubMed ID: 15533515
[TBL] [Abstract][Full Text] [Related]
4. Incidence and management of hot flashes in prostate cancer.
Spetz AC; Zetterlund EL; Varenhorst E; Hammar M
J Support Oncol; 2003; 1(4):263-6, 269-70, 272-3; discussion 267-8, 271-2. PubMed ID: 15334868
[TBL] [Abstract][Full Text] [Related]
5. Hot flushes in healthy aging men differ from those in men with prostate cancer and in menopausal women.
Holm AC; Thorell LH; Theodorsson E; Hammar M
Gynecol Endocrinol; 2012 Jan; 28(1):72-5. PubMed ID: 21878036
[TBL] [Abstract][Full Text] [Related]
6. Skin temperature rise induced by calcitonin gene-related peptide in gonadotropin-releasing hormone analogue-treated female rats and alleviation by Keishi-bukuryo-gan, a Japanese herbal medicine.
Noguchi M; Ikarashi Y; Yuzurihara M; Kase Y; Watanabe K; Plotnikoff GA; Takeda S; Aburada M
Life Sci; 2005 Mar; 76(18):2079-90. PubMed ID: 15826875
[TBL] [Abstract][Full Text] [Related]
7. The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial.
Borud EK; Alraek T; White A; Fonnebo V; Eggen AE; Hammar M; Astrand LL; Theodorsson E; Grimsgaard S
Menopause; 2009; 16(3):484-93. PubMed ID: 19423996
[TBL] [Abstract][Full Text] [Related]
8. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
Ulloa EW; Salup R; Patterson SG; Jacobsen PB
Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
[TBL] [Abstract][Full Text] [Related]
9. Involvement of calcitonin gene-related peptide in elevation of skin temperature in castrated male rats.
Yuzurihara M; Ikarashi Y; Noguchi M; Kase Y; Takeda S; Aburada M
Urology; 2003 Nov; 62(5):947-51. PubMed ID: 14624932
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.
Spetz AC; Hammar M; Lindberg B; Spångberg A; Varenhorst E;
J Urol; 2001 Aug; 166(2):517-20. PubMed ID: 11458057
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women.
Wyon YA; Spetz AC; Theodorsson GE; Hammar ML
Menopause; 2000; 7(1):25-30. PubMed ID: 10646700
[TBL] [Abstract][Full Text] [Related]
12. Validation of sternal skin conductance for detection of hot flashes in prostate cancer survivors.
Hanisch LJ; Palmer SC; Donahue A; Coyne JC
Psychophysiology; 2007 Mar; 44(2):189-93. PubMed ID: 17343702
[TBL] [Abstract][Full Text] [Related]
13. Increases in core body temperature precede hot flashes in a prostate cancer patient.
Hanisch LJ; Mao JJ; Gehrman PR; Vaughn DJ; Coyne JC
Psychooncology; 2009 May; 18(5):564-7. PubMed ID: 19025973
[TBL] [Abstract][Full Text] [Related]
14. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks.
Gupta P; Harte A; Sturdee DW; Sharma A; Barnett AH; Kumar S; McTernan PG
Climacteric; 2008 Oct; 11(5):364-72. PubMed ID: 18781480
[TBL] [Abstract][Full Text] [Related]
15. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the neuropeptide Y Y1 receptor affects pain sensitivity, neuropeptide transport and expression, and dorsal root ganglion neuron numbers.
Shi TJ; Li J; Dahlström A; Theodorsson E; Ceccatelli S; Decosterd I; Pedrazzini T; Hökfelt T
Neuroscience; 2006 Jun; 140(1):293-304. PubMed ID: 16564642
[TBL] [Abstract][Full Text] [Related]
17. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study.
Hammar M; Frisk J; Grimås O; Höök M; Spetz AC; Wyon Y
J Urol; 1999 Mar; 161(3):853-6. PubMed ID: 10022700
[TBL] [Abstract][Full Text] [Related]
18. Acupuncture for hot flashes in patients with prostate cancer.
Beer TM; Benavides M; Emmons SL; Hayes M; Liu G; Garzotto M; Donovan D; Katovic N; Reeder C; Eilers K
Urology; 2010 Nov; 76(5):1182-8. PubMed ID: 20494414
[TBL] [Abstract][Full Text] [Related]
19. Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study.
Pettersson B; Varenhorst E; Petas A; Sandow J
Eur Urol; 2006 Sep; 50(3):483-9. PubMed ID: 16626856
[TBL] [Abstract][Full Text] [Related]
20. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
Dumont Y; Chabot JG; Quirion R
Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
